| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |